Bank of America
BBC icon

Bank of America’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Bank of America’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,175
Closed -$54K – 8210
2021
Q3 		$54K Buy
+1,175
New +$54.9K ﹤0.01% 7005
2020
Q1 		– Sell
-126
Closed -$5K – 6838
2019
Q4 		$5K Buy
+126
New +$3.75K ﹤0.01% 6757
2019
Q3 		– Sell
-590
Closed -$17K – 7250
2019
Q2 		$17K Hold
590
– – ﹤0.01% 6603
2019
Q1 		$17K Buy
+590
New +$15.5K ﹤0.01% 6528
2017
Q3 		– Sell
-350
Closed -$8K – 7049
2017
Q2 		$8K Buy
+350
New +$7.84K ﹤0.01% 6482

Other funds holding BBC

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Bank of America's BBC Position: Q4 2021 in Review

Bank of America sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q4 2021, closing a stake of 1,175 shares — an estimated $54K sold.

Bank of America first reported a position in BBC in Q2 2017 and held it in 5 quarters. The position peaked at $54K in Q3 2021. 19 funds tracked by Wall St. Rank hold BBC as of Q4 2021.

  • Bank of America reported no remaining Virtus Biotech Clinical Trials ETF position as of Q4 2021 after selling out during the quarter.
  • Bank of America sold 1,175 Virtus Biotech Clinical Trials ETF shares in Q4 2021, an estimated $54K.
  • Bank of America first reported a position in Virtus Biotech Clinical Trials ETF in Q2 2017 and held it in 5 quarters.
  • Bank of America's Virtus Biotech Clinical Trials ETF position peaked at $54K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q4 2021.

Based on Bank of America's 13F filing for Q4 2021, filed 8 Feb 2022.